Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Oncology
12 Dec 2015
Evaluating the experience of surviving at least five years after a prostate cancer diagnosis
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Natalie Doyle, MSc, RGN, Nurse Consultant at The Royal Marsden NHS…
Oncology
11 Dec 2015
Improving adherence to oral therapies in clinical practice
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Cheryl Vidall, Head of Nursing and Governance at Alcura UK Limited, Alton…
Oncology
11 Dec 2015
Telephone assessment service for patients receiving ipilimumab for metastatic melanoma
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Joanne Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge…
Oncology
11 Dec 2015
Integrating psychological support and physical activity interventions in cancer care
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Margaret Oakes, Specialist Counselling Psychologist at Berkshire…
Oncology
11 Dec 2015
Improving survivorship services in haemato-oncology
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Michelle Taylor, Clinical Nurse Specialist, of The Great Western Hospital…
Oncology
11 Dec 2015
Optimising the assessment of sexuality in oncology
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Michael Mawhinney, doctoral research student, Oxford Brookes University…
Oncology
11 Dec 2015
A new model of care for lung cancer patients
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Lisa Wells, Macmillan Lung Cancer Clinical Nurse Specialist, of…
Oncology
11 Dec 2015
Developing a self-management programme to support prostate and testicular cancer survivors
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Andrew Turner, discusses a qualitative study of the self-management needs…
Oncology
11 Dec 2015
Defining the elements of the acute oncology nursing role
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ali Hodge, Advanced Nurse Practitioner for Acute Oncology at The Royal…
Oncology
11 Dec 2015
Chemotherapy-induced nausea and vomiting – a nurse’s perspective
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Annie Young, SRN, PhD, Professor of Nursing, University of Warwick…
Oncology
11 Dec 2015
Physical activity, obesity and cancer
Martin Wiseman, MD talks about how the environment we live in determines the patterns of cancer across the world. There is now an increasingly large…
Oncology
11 Dec 2015
The use of supplements to complement a healthy and balanced diet for prostate cancer patients
Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the results of the Pomi-T clinical trial. The study focused on the effects of Pomi-T on prostate-specific…
Oncology
11 Dec 2015
Strategies to cope with cancer therapy side-effects
Robert Thomas, MbChb, MRCP, MD, FRCR, discusses non-medicinal strategies to help cancer patients cope with cancer therapy side-effects. Prof. Robert…
Oncology
11 Dec 2015
The importance of a healthy and balanced diet for cancer patients
Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the importance of having a healthy diet for cancer patients. Prof. Robert Thomas suggests that cancer…
Oncology
11 Dec 2015
Addressing patient safety at the UKONS Annual Conference 2015
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, which attracts cancer nurses from around the United Kingdom and beyond…
Oncology
11 Dec 2015
Molecular drivers of metastatic disease in breast cancer
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, explains that genetic…
Oncology
11 Dec 2015
Clinical implications of malnourishment in cancer care
At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching Hospital, St. Helens, UK…
Oncology
11 Dec 2015
Nivolumab and cabozantinib versus standard of care in renal cell carcinoma
Thomas Powles, MBBS, MRCP, MD, of Barts and The London School of Medicine and Dentistry, London, UK, discusses the results of clinical trials reported…
Oncology
11 Dec 2015
Overcoming acquired resistance to targeted therapies in lung cancer
At the European Cancer Congress (ECC) 2015, David Ross Camidge, MD, PhD, of the University of Colorado Cancer Center, Aurora, CO, explains that…
Oncology
11 Dec 2015
The DETECT study: Personalised treatment in advanced breast cancer based on circulating tumour cells
At the European Cancer Congress (ECC) 2015, Wolfgang Janni, MD, PhD University Hospital Ulm, Ulm, discusses the interim analysis of the DETECT study…
Oncology
11 Dec 2015
The impact of the Oncotype DX® Breast Cancer Assay on the patient treatment journey
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Oncology
11 Dec 2015
ASPIRE-PCa: Prospective, global observational study of men with late-stage prostate cancer
At the European Cancer Congress (ECC) 2015, Maria De Santis, MD, of the University of Warwick, Warwick, UK, discusses the initial results of ASPIRE-PCa…
Oncology
11 Dec 2015
Seropositivity to tumour antigens as a potential new biomarker for melanoma relapse
At the European Cancer Congress (ECC) 2015, Paul Nathan, MB.BS, BSc (Hons), BA, PhD, FRCP, of Mount Vernon Cancer Centre, Northwood, UK, discusses a…
Oncology
11 Dec 2015
Biomarker-driven therapies for triple-negative breast cancer
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, discusses molecular subgroups…
Oncology
11 Dec 2015
Improving access to innovation in cancer care in Europe
At the European Cancer Congress (ECC) 2015, Matti Aapro, MD, of Clinique de Genolier, Genolier, Switzerland, describes the European School of Oncology…
Oncology
9 Dec 2015
Changing the standard of care in previously treated metastatic renal cell carcinoma
At the European Cancer Congress (ECC) 2015, Laurence Albiges, MD, of Institut Gustave Roussy, Villejuif, France, discusses the results of clinical trials…
Oncology
9 Dec 2015
POPLAR: Phase 2 trial of atezolizumab monotherapy in non-small cell lung cancer
At the European Cancer Congress (ECC) 2015, Johan Vansteenkiste, MD, PhD, of KU Leuven, Leuven, Belgium, discusses the primary analyses of efficacy…
Oncology
9 Dec 2015
Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
At the European Cancer Congress (ECC) 2015, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Victoria, Australia…
Oncology
9 Dec 2015
AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer
At the European Cancer Congress (ECC) 2015, Eric Pujade-Lauraine, MD, PhD, of Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris…
Oncology
9 Dec 2015
Deciding which of the available genomic tests to use
Multigene assays may provide clinically complementary information to classic clinicopathological tumour features, such as tumour size and grade, in…
Oncology
9 Dec 2015
Progress in the treatment of BRAF-mutant melanoma
At the European Cancer Congress (ECC) 2015, Dirk Schadendorf, MD, PhD, of Universitätsklinikum Essen, Essen, Germany, discusses the advances in the…
Oncology
9 Dec 2015
BIRCH: Phase 2 trial of atezolizumab for advanced PD-L1-selected non-small cell lung cancer
At the European Cancer Congress (ECC) 2015, Benjamin Besse, MD, PhD, of Institut Gustave Roussy, Villejuif, France, discusses BIRCH, a phase 2, single…
Oncology
9 Dec 2015
BELIEF: Phase 2 trial of erlotinib and bevacizumab in non-small cell lung cancer
At the European Cancer Congress (ECC) 2015, Bartomeu Massuti, MD, of Hospital General de Alicante, Alicante, Spain, discusses the Spanish Lung Cancer…
Oncology
9 Dec 2015
MASTERKEY-265: Phase 1b/3 trial of T-VEC and pembrolizumab for unresectable stage IIIB-IV melanoma
At the European Cancer Congress (ECC) 2015, Georgina Long, BSc, PhD, MBBS, FRACP, of The University of Sydney, Sydney, Australia, discusses the safety…
Oncology
9 Dec 2015
Involving patients in the use of their data
Chris Carrigan of the National Cancer Intelligence Network (NCIN), discusses the uses of the enormous amount of data collected by NHS on a daily basis…
Oncology
9 Dec 2015
2015 NCRI Cancer Conference highlights and new NCRI initiatives
Karen Kennedy, PhD, Director of the National Cancer Research Institute (NCRI), gives an overview of the 2015 NCRI Cancer Conference. The conference…
Oncology
9 Dec 2015
Epigenetic targets in cancer
Kristian Helin, PhD gives an overview of his talk on epigenetic targets in cancer presented at the 2015 National Cancer Research Institute (NCRI) Cancer…
Oncology
9 Dec 2015
Breast Cancer Now: aiming to prevent death from breast cancer by 2050
Robert Coleman, MBBS, MD, FRCP, a trustee of Breast Cancer Now, discusses the goals of the newly formed charity that resulted from the combination of…
Innovations
9 Dec 2015
Is late diagnosis of cancer real and if so, what can we do about it?
Harpal Kumar, MA MEng MBA DSc gives an overview of his session at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where he…
Oncology
9 Dec 2015
Investigating the genomic landscape of brain tumours using metabolic imaging
Kevin Brindle, PhD gives an overview of his talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where he described a new…
Oncology
9 Dec 2015
Systematic assessment of patient and carer needs in the oncology clinical and GP surgery
Miriam Johnson, MD gives an overview of a session at at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, that focuses on the…
Oncology
9 Dec 2015
How many cancers can we prevent through dietary modifications?
Paolo Boffetta, MD, MPH gives an overview of his talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. In his talk he discusses…
Oncology
9 Dec 2015
Molecular testing for early cancer diagnosis: ready for prime time
Rebecca Fitzgerald, MD, FAAD gives an overview of a session presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, focusing…
Oncology
9 Dec 2015
The origins of CDK by Tim Hunt
Tim Hunt, FRS, FMedSci describes the path that led him to identify cyclin-dependent kinases (CDK), along with colleagues Paul Nurse and Leland Hartwell…
Oncology
9 Dec 2015
Chemoprevention in breast cancer
Jack Cuzick, PhD, FMedSci, FRCP(hon), of the Queen Mary University of London, UK gives an overview of the session ‘Prevention is better than cure’…
Oncology
9 Dec 2015
Tumour: stroma interactions
In the session ” Tumour: stroma interactions” presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, the importance of…
Diabetes
1 Dec 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?
A full recording of the Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm…
Diabetes
26 Nov 2015
Optimal Management of Post-ACS T2D Patients: Panel Discussion
Prof Jean-Claude Tardif, Prof Stephen Nicholls, Prof Jørgen Rungby, and Prof Faiez Zannad respond to audience questions in a Q&A session chaired by Prof…
Diabetes
26 Nov 2015
The ACS Patient Journey: Where Does T2 Diabetes Fit In?
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
What Do We Know About the Safety of OADs in Post-ACS Patients? Exploring Evidence from Recent Outcomes Studies
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
Diabetologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
Cardiologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients? Opening Remarks
Prof Ele Ferrannini of the University of Pisa School of Medicine, Pisa, Italy, welcomes congress delegates to a Takeda-sponsored symposium held at the…
Oncology
19 Nov 2015
Genomics England: 100,000 Genomes Project
Clare Turnbull, MD, PhD, gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where the Genomics…
Oncology
19 Nov 2015
Reducing prostate cancer progression and mortality: what patients can do to reduce risk
Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr Kenfield talks about how…
Oncology
19 Nov 2015
Helping healthcare professionals initiate conversations about physical activity
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is implementing…
Oncology
19 Nov 2015
Keeping active with Macmillan Cancer Support
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb gives an overview of a new Macmillan Cancer Support initiative aimed…
Oncology
19 Nov 2015
Physical activity – the panacea?
Robert Thomas, MbChb, MRCP, MD, FRCR, gives an overview of the session “Physical activity – the panacea?” at the 2015 National Cancer Research Institute…
Oncology
19 Nov 2015
The development of genomic tests and how validation affects their use in the clinic
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: Francis Crick Institute scientists
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, discusses topics covered…
Oncology
19 Nov 2015
Clonal evolution in colorectal cancer
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Alberto Bardelli, PhD talks about clonal evolution in colorectal cancer. He also…
Oncology
19 Nov 2015
Update on CheckMate 067, an advanced melanoma clinical trial
James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or Nivolumab plus Ipilimumab versus Ipilimumab…
Oncology
19 Nov 2015
Physical activity levels and barriers to exercise referral among patients with cancer
Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients with cancer, at the…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: Featured sessions
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
Loading posts...
« Previous
1
…
70
71
72
73
74
…
99
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View